Barrett Esophagus: Updated Guideline Recommendations

Routine screening in women with gastroesophageal reflux disorder is not recommended.

Sponsoring Organization: American College of Gastroenterology (ACG)

Target Audience: Gastroenterologists, general internists

Background and Objective

Considerable controversy surrounds the cost-effectiveness of screening and surveillance for Barrett esophagus (BE) as well as the role of ablative therapies aimed at decreasing the related esophageal adenocarcinoma (EAC) risk. The ACG has evaluated the most current published clinical reports on this topic and now offers evidence-based, weighted recommendations on current best practices.

Key Recommendations

Screening

Do not routinely screen women with gastroesophageal reflux disease (GERD) symptoms.
Screen men with chronic (lasting >5 years) GERD symptoms and ≥2 risk factors for BE or EAC (age >50 y…

Reviewing Author

David A. Johnson, MD

Disclosures

Consultant/Advisory boardMedscape/WebMD; Pfizer; CRH Medical Corporation; Aries

EquityCRH Medical Corporation

Editorial boardsMedscape Gastroenterology

Leadership positions in professional societiesAmerican College of Gastroenterology Research Institute Board of Directors